GenMark Diagnostics, Inc. (GNMK) [Rocket]

Overview

GenMark Diagnostics, Inc. (GNMK)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
02/14/2022	SC 13G/A	Consonance Capital Management LP reports a 0% stake in GENMARK DIAGNOSTICS INC
05/10/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/03/2021	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
04/28/2021	EFFECT	Form EFFECT - Notice of Effectiveness:
04/22/2021	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/22/2021	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
Revenues	171.6	88.0	70.8	52.5	49.3	39.4	30.6	27.4
Revenue growth	94.9%	24.4%	34.7%	6.6%	25.0%	28.8%	11.6%	33.9%
Cost of goods sold	103.6	59.4	51.3	32.5	19.7	15.3	13.1	15.6
Gross profit	67.9	28.6	19.5	20.0	29.6	24.1	17.5	11.8
Gross margin	39.6%	32.5%	27.5%	38.1%	60.0%	61.1%	57.1%	43.2%
Sales and marketing	23.2	24.1	21.8	20.6	14.7	14.4	12.6	12.8
Research and development	30.3	27.1	27.9	42.8	49.5	37.5	31.8	22.1
General and administrative	25.6	19.2	17.5	16.2	14.4	13.8	12.1	11.8
EBITA	-10.5	-41.2	-47.8	-59.0	-48.6	-41.2	-38.8	-34.5
EBITA margin	-6.1%	-46.8%	-67.5%	-112.3%	-98.6%	-104.6%	-126.9%	-126.0%
Amortization of intangibles	0.6	0.6		0.5	0.4	0.3	0.2	0.3
EBIT	-11.1	-41.8	-47.8	-59.5	-49.0	-41.5	-39.1	-34.9
EBIT margin	-6.4%	-47.5%	-67.5%	-113.3%	-99.4%	-105.4%	-127.7%	-127.3%
Pre-tax income	-18.6	-47.3	-50.4	-61.7	-50.5	-42.2	-38.8	-33.6
Income taxes	0.1	0.1	0.1	0.1	0.1	0.0	-0.6	0.0
Tax rate							1.5%
Net income	-18.6	-47.4	-50.5	-61.9	-50.6	-42.2	-38.3	-33.6
Net margin	-10.9%	-53.8%	-71.4%	-117.8%	-102.7%	-107.1%	-125.1%	-122.8%

Diluted EPS	($0.28)	($0.82)	($0.91)	($1.21)	($1.15)	($1.00)	($0.93)	($0.95)
Shares outstanding (diluted)	67.5	57.6	55.7	51.2	44.1	42.2	41.3	35.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.